For patients with advanced or metastatic RCC, fruquintinib plus sintilimab improves PFS compared to investigator’s choice of axilitinib or everolimus.

(HealthDay News) — From 2003 to 2017, cancer incidence rates increased for several cancer types, with increases in younger and older adults for many cancers, according to a study published online Oct.

Poor blood sugar control in adolescence increases likelihood for developing neuropathy in adulthood. (HealthDay News) — Poor blood sugar control in adolescents with type 1 diabetes (T1D) increases the ...

Investigators presented initial results from a phase 3 trial of adjuvant durvalumab plus tremelimumab for resected primary renal cell carcinoma (RCC).

First-line treatment with disitamab vedotin and toripalimab improved outcomes over chemotherapy in patients with HER2-expressing, locally advanced or metastatic urothelial carcinoma.

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

Nearly 700 medicines used in the U.S. to treat common conditions contain at least one chemical sourced only in China.

Gerhardt Attard, M.D., Ph.D., from University College London, and colleagues conducted a double-blind trial that evaluated combining niraparib with AAP versus placebo and AAP in mCSPC with HRR gene ...

Based on 13 studies, the meta-analysis revealed loneliness and social isolation were associated with increased all-cause mortality (hazard ratio, 1.34; P < 0.001) and cancer-specific mortality (hazard ...

(HealthDay News) — Among survivors of drug overdose, fewer than half visited the emergency department, according to a study published online in JAMA Network Open.

Cancer deaths have increased by more than 70% globally over the last 3 decades and are estimated to continue to climb, researchers report.

(HealthDay News) — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes ...